title: Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.
authors.forename: W
authors.initials: W
authors.lastname: Rozenbaum
authors.forename: D
authors.initials: D
authors.lastname: Dormont
authors.forename: B
authors.initials: B
authors.lastname: Spire
authors.forename: E
authors.initials: E
authors.lastname: Vilmer
authors.forename: M
authors.initials: M
authors.lastname: Gentilini
authors.forename: C
authors.initials: C
authors.lastname: Griscelli
authors.forename: L
authors.initials: L
authors.lastname: Montagnier
authors.forename: F
authors.initials: F
authors.lastname: Barre-Sinoussi
authors.forename: J C
authors.initials: JC
authors.lastname: Chermann
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000965:Antimony / Q000627:therapeutic use*; D017977:Deltaretrovirus / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D014414:Tungsten / Q000627:therapeutic use*; D017973:Tungsten Compounds
chemical_list: D017973:Tungsten Compounds; C009613:ammonium tungsten antimonate hydroxide oxide; D000965:Antimony; D014414:Tungsten